Fierce Pharma

NOVEMBER 14, 2024

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy has already been approved to treat AADC deficiency in Europe and the U.K., among other countries, where it's branded as Upstaza.

FDA 114

FDA 114

Med Ed 101

DECEMBER 3, 2017

For those of you looking for BCPS help in the next year or two, you better not wait any longer – This one time only initial offer will end Monday December 4th, 2017! The post Day 1 – ASHP Midyear Meeting 2017 appeared first on Med Ed 101.

40

40

Med Ed 101

FEBRUARY 8, 2017

Where are we at with 2017 Pharmacist Provider Status? The post 2017 Pharmacist Provider Status Update appeared first on Med Ed 101. Since the heated election, a host of topics and discussions have been held on National debt and Healthcare. There is really positive news regarding pharmacist provider status.

40

40

Med Ed 101

DECEMBER 6, 2017

The post ASHP Midyear 2017 Day 4 appeared first on Med Ed 101. Hope you all enjoyed it, and maybe I will head back next year…we’ll see! Day 4 of ASHP Midyear took on a medication safety theme. I took part in a pain management in opioid use […].

40

40

Med Ed 101

DECEMBER 5, 2017

The post ASHP Midyear Day 2 2017 appeared first on Med Ed 101. With ongoing discussions today with more pharmacists, residents and students, I can’t help but think what pharmacy is going to look like in 10 or 20 years. I think the key to identifying what’s going to happen is to think […].

40

40

Med Ed 101

DECEMBER 13, 2017

The post New Hypertension Guideline Update – 2017 appeared first on Med Ed 101. I outline some of the important differences in the presentation below. I have also added this to the 20+ hour BCPS pharmacotherapy webinar. I’m giving year long access for […].

40

40

Med Ed 101

JANUARY 7, 2018

I’m a few days late to the game here, but I wanted to share my 3 biggest clinical pharmacy changes from 2017. My opinion of course, and I’d love it if you would post one or two things below that you felt were important clinical updates in 2017. How did I select these? Without further […].

40

40

Med Ed 101

DECEMBER 5, 2017

Day 3 at ASHP 2017 has been a little more depressing due to the pharmacist job market. The post Pharmacist Job Market Outlook – ASHP Midyear 2017 Day 3 (Tuesday) appeared first on Med Ed 101. The post Pharmacist Job Market Outlook – ASHP Midyear 2017 Day 3 (Tuesday) appeared first on Med Ed 101.

40

40

STAT

OCTOBER 12, 2023

Good morning, everyone, and welcome to another busy day. We are scrambling, in fact, to update our to-do list, schedule online calls, and sort out deadlines. To cope, we are quaffing several cups of stimulation, of course. Our choice today is maple bourbon. Meanwhile, here is the latest selection of interesting items for you to peruse.

100

100

Pharmacy Times

JULY 24, 2024

In April 2017, the drug was approved to treat the slow loss of the ability to walk for symptomatic patients aged 3 and older who had Batten disease.

FDA 122

FDA 122

Drug Topics

APRIL 12, 2024

Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.

FDA 154

FDA 154

Fierce Pharma

FEBRUARY 13, 2024

It’s the approval Ipsen has been waiting for since buying up Onivyde in 2017. It’s the approval Ipsen has been waiting for since buying up Onivyde in 2017. The FDA has approved Onivyde as part of a combination dubbed Nalirifox to treat patients with newly diagnosed metastatic pancreatic cancer.

FDA 113

FDA 113

Med Ed 101

NOVEMBER 30, 2016

As a practicing pharmacist, I continue to hear rumblings and news trickle in about the 2017 pharmacy job outlook. As I focus ahead to the 2017 pharmacy job outlook, Pharmacist […]. The post The 2017 Pharmacy Job Outlook – What A Facebook Ad Can Tell Us appeared first on Med Ed 101.

40

40

Fierce Pharma

SEPTEMBER 13, 2024

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in- | The day after Roche gained an FDA approval for its subcutaneous version of cancer drug Tecentriq, the company also scored with a U.S. nod for its under-the-skin formulation of mega-blockbuster multiple sclerosis drug Ocrevus.

FDA 117

FDA 117

STAT

JULY 31, 2024

These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.

145

145

STAT

OCTOBER 10, 2024

Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017. He said then that he didn’t have children because of concerns he would pass on the disease to them. 

137

137

Pharmacy Times

DECEMBER 21, 2023

The cost of defending license matters and malpractice claim costs have increased over a 5-year period (2017-2022).

132

132

Med Ed 101

AUGUST 30, 2017

The post 2017 Pharmacist Board Certification Pass Rates – How Hard is BCPS, BCACP, BCGP, etc. I breakdown the recent release from Board of Pharmaceutical Specialties and give you a sense of what you are up against. If you are looking for study material for pharmacist board certifications, click […].

40

40

STAT

SEPTEMBER 18, 2024

In 2017, at the age of 42, Susan Whitehead was diagnosed with an early form of breast cancer after discovering a lump in her breast. She embarked on a challenging path of treatment, including a recurrence with stage 2 cancer four years later. Susan underwent two lumpectomies, a mastectomy, radiation, and chemotherapy.

Chemotherapy 125

Chemotherapy 125

Pharmacy Times

APRIL 11, 2024

Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.

FDA 111

FDA 111

Fierce Healthcare

APRIL 19, 2024

The company, which launched in 2017, has contracts with four cities for its network of AEDs to improve survival rates of sudden cardiac arrest. Portable defibrillator company Avive Solutions raised $56.5 million in growth equity financing to build out its staff and commercial developments. |

113

113

pharmaphorum

APRIL 8, 2024

Less than half of the cancer therapies given accelerated approval by the FDA in 2013 to 2017 showed a clinical benefit in a confirmatory trial within the next five years

FDA 106

FDA 106

STAT

OCTOBER 31, 2024

Between 2017 and 2021, regulators in the U.S. Of 104 reports of supply chain issues with dozens of drugs, meaningful shortages were 40% less likely to occur in Canada than in the U.S., a new study found, and the difference was largely attributed to the approach taken by the Canadian government to the problem.

FDA 135

FDA 135

Pharmacy Times

DECEMBER 9, 2022

The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.

139

139

Fierce Pharma

MARCH 20, 2024

After Johnson & Johnson last year changed its mind on its 2017 purchase of ap | Idorsia's Tryvio is the first oral anti-hypertensive therapy that uses a new therapeutic mechanism in nearly 40 years, suggesting the dawn of "a new era of endothelin research," the company said.

FDA 116

FDA 116

STAT

JUNE 6, 2024

Federal officials, medical organizations, and reproductive health advocacy groups have expressed outrage in response to STAT’s recent investigation revealing that women with sickle cell disease have felt pressured into sterilizations as recently as 2017 and 2022.

144

144

Fierce Pharma

APRIL 8, 2024

Many cancer meds approved under the FDA's accelerated approval pathway from 2013 to 2017 didn't improve overall survival after more than five years of follow-up research, the study found. One hallmark of the FDA's accelerated approval pathway is the requirement that medicines prove their benefits in confirmatory trials.

FDA 115

FDA 115

Pharmacy Times

DECEMBER 22, 2022

Alex Barker founded The Happy PharmD to provide career coaching and career development classes, and since 2017, the company has helped over 1,500 pharmacists.

132

132

Pharmaceutical Technology

NOVEMBER 28, 2023

Venture financing for innovative radiopharmaceutical drugs witnessed an approximately 550% increase from $63m in 2017 to $408m in 2023 YTD (year-to-date) total deal value in the US.

98

98

STAT

MAY 28, 2024

A new investigation, published on Friday in JAMA Network Open , confirmed the link to early deliveries at a massive scale, in a large cohort study capturing over half of the births that occurred in the United States between 1993 and 2017. Its results shed light on the way existing health inequities may be exacerbated by a worsening climate.

139

139

Fierce Pharma

NOVEMBER 7, 2023

Since launching the Regeneron-partnered antibody Dupixent in 2017, Sanofi has relied on the star medicine for sales growth.

Communication 94

Communication 94

Fierce Pharma

JULY 27, 2023

scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. scored a legal win in the insurance case tied to the 2017 "NotPetya" cyberattack, the case is in appeals—again. About a month and a half after Merck & Co. That didn't take long.

Insurance 89

Insurance 89

STAT

APRIL 3, 2024

That was until 2017, when he founded a startup called Nucleai. For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing satellite images. Now, he’s scouring biopsy samples for cancer cells. Nucleai’s technology is not searching out signs of danger.

137

137

The FDA Law Blog

NOVEMBER 6, 2024

The Court looked to the “statute’s words, structure, and historical context” and found that they “establish that, when Congress amended the [Orphan Drug Act] in 2017, it ratified and incorporated the existing regulatory definition of ‘same drug’ into the statute.”

FDA 109

FDA Labelling Patient Care 109

Fierce Pharma

JUNE 20, 2024

The revised deal, first established back in July of 2017, will now see Baxter pay Samsung upwards of $223 million for its manufacturing services through end of 2034. On a revised dealmaking spree this year, Korea’s Samsung Biologics is re-tooling its long-running drug manufacturing pact with Baxter Healthcare. |

91

91

Drug Store News

AUGUST 3, 2023

After reviewing products projected to succeed from 2017 to 2022, the categories with the largest number of new items on shelves are first aid, pain relief, oral care and eye and ear care.

97

97

STAT

OCTOBER 10, 2024

The kickback case began four years ago when the Department of Justice accused Teva of using the foundations to ensure that, from 2006 through 2017, Medicare patients did not have to make a copayment or deductible for the Copaxone multiple sclerosis drug. At the same time, Teva steadily raised the price of its drug by thousands of dollars.

Pharmaceutical Companies 126

Pharmaceutical Companies Pharmaceutical Companies 126